Anxiety and Depression Perceived by Individuals With and Without Cancer During the COVID-19 Pandemic Period

CompletedOBSERVATIONAL
Enrollment

1,107

Participants

Timeline

Start Date

May 8, 2020

Primary Completion Date

June 25, 2020

Study Completion Date

June 25, 2020

Conditions
AnxietyDepressionCovid19CancerChronic Disease
Interventions
DIAGNOSTIC_TEST

Hospital Anxiety Depression Scale

HADS is a self-report questionnaire designed to screen the symptoms of anxiety and depression in individuals with medical diseases other than psychiatric illnessesHADS is a self-report questionnaire designed to screen the symptoms of anxiety and depression in individuals with medical diseases other than psychiatric illnesses The 4-point Likert type scale, which consists of 14 items, has 2 subscales. Each of the HADS-Anxiety (HADS-A) and HADS-Depression (HADS-D) subscales has 7 items. The score given for each question varies between 0 and 3. A high score indicates a high level of anxiety and depression. The responses given to the questions are given certain scores, and as a result, a score of 0-7 refers to a normal level, 8-10 to a level at the limit and 11 and above to a high level (abnormal level).

Trial Locations (1)

34660

Sultan Abdülhamid Han Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

OTHER